The effect of traumatic brain injury upon the concentration and expression of interleukin-1β and interleukin-10 in the rat

Journal of Trauma - Injury, Infection and Critical Care

Volumn 60, Issue 1, 2006, Pages 152-157

  Kamm, Keira ^a,d   VanderKolk, Wayne ^a,b   Lawrence, Chuck ^a   Jonker, Mark ^c   Davis, Alan T ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b SPECTRUM HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d University of Wisconsin ^*  (United States)

Author keywords

Animal model; Cytokines; Traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BRAIN LEVEL; CONTROLLED STUDY; GENE EXPRESSION; IMMUNE RESPONSE; INJURY SEVERITY; LIVER LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; BRAIN INJURY; DISEASE MODEL; GENETICS; LIVER; METABOLISM; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BRAIN; BRAIN INJURIES; DISEASE MODELS, ANIMAL; INTERLEUKIN-1; INTERLEUKIN-10; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646083015     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ta.0000196345.81169.a1     Document Type: Article

References (44)

1. Abdel-Dayem HM, Abu-Judeh H, Kumar M, et al. SPECT brain perfusion abnormalities in mild or moderate traumatic brain injury. Clin Nucl Med. 1998;23:309-317.
2. Weight DG. Minor head trauma. Psych Clin N Am. 1998;21:609-624.
3. Borczuk P. Mild head trauma. Emerg Med Clin N Am. 1998;15:563-579.
4. Centers for Disease Control and Prevention. Traumatic brain injury, Colorado, Missouri, Oklahoma, and Utah - 1990-1993. MMWR Morb Mortal Wkly Rep. 1997;46: 8-11.
5. Thurman DJ, Alverson C, Dunn, et al. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. 1999; 602-615.
6. Lau LT, Cheung-Hoi Yu A. Astrocytes Produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury. J Neurotrauma. 2001;18:351-359.
7. Knoblach SM, Faden AI. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol. 1998;153:143-151.
8. Marciano PG, Eberwine JH, Ragupathi R, et al. Expression profiling following traumatic brain injury: a review. Neurochem Res. 2002;27:1147-1155.
9. Stahel PF, Kossmann T, Joller H, et al. Increased interleukin-12 levels in human cerebrospinal fluid following severe head trauma. Neurosci Lett. 1998;249:123-126.
10. McClain CJ, Cohen D, Ott L, et al. Ventricular fluid interleukin-1 activity in patients with head injury. J Lab Clin Med. 1987;110:48-54.
11. Ross SA, Halliday MI, Campbell GC, et al. The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg. 1994;8:419-425.
12. Csuka E, Morganti-Kossman MC, Lenzlinger PM, et al. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood-brain barrier function. J Neuroimmunol. 1999;101:211-221.
13. Taupin V, Toulmond S, Serrano A, et al. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesions. Influence of pre-and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol. 1993;42:177-185.
14. Tehranian R, Andell-Jonsson S, Beni SM, et al. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J Neurotrauma. 2002;19:939-951.
15. Benveniste EN, Tang LP, Law RM. Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. Int J Dev Neurosci. 1995;13:341-349.
16. Bogdan C, Paik J, Vodovotz Y, et al. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem. 1992;267:23301-23308.
17. Chao CC, Hu S, Sheng WS, et al. Tumor necrosis factor-alpha production by human fetal microglial cells. Regulation of other cytokines. Dev Neurosci. 1995;17:97-105.
18. Hoedema RE, Vanderkolk W. Interleukin-1 concentrations are positively correlated to interleukin-10 concentrations in cerebral spinal fluid of closed head injury patients. Presented at the 14th Annual Meeting of the Eastern Association for the Surgery of Trauma, January 8-13, 2001, Tampa Bay, Florida.
19. Marmarou A, Abd-Elfattah Foda MA, Van Den Brink W, et al. A new model of diffuse brain injury in rats, Part I: Pathophysiology and biomechanics. J Neurosurg. 1994;80:291-300.
20. Abd-Elfattah Foda MA, Marmarou A. A new model of diffuse brain injury in rats, Part II: Morphological characterization. J Neurosurg. 1994;80:301-313.
21. Raff T, van der Giet M, Endemann D, et al. Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques. 1997;23:456-460.
22. Kipnis NJ, Panikashvili U, Alexandrovich A, et al. Therapeutic vaccination for closed head trauma. J Neurotrauma. 2003;20:559-569.
23. Fink MP. The role of cytokines as mediators of the inflammatory response. In: Townsend CM Jr, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston Textbook of Surgery. Philadelphia: Elsevier, 2004:50-56.
24. Toulmond S, Rothwell NJ. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res. 1995;671:261-266.
25. Sanderson KL, Raghupathi R, Saatman KF, et al. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury. J Cereb Blood Flow Metab. 1999;19:118-125.
26. Holmin S, Matheisen T. Intracerebral administration of interleukin-1β and induction of inflammation, apoptosis, and vasogenic edema. J Neurosurg. 2000;92:108-120.
27. Ciallella JR, Ikonomovic MD, Paljug WR, et al. Changes in expression of amyloid precursor protein and interleukin-1β after experimental traumatic brain injury in rats. J Neurotrauma. 2002;19:1555-1567.
28. Stahel PF, Shohami E, Younis FM, et al. Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab. 2000;20:369-380.
29. De Waal Malefyt R, Haanen J, Spits H, et al. Interleukin-10 and viral IL-10 strongly reduce the antigen-specific human T-cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991;174:915-924.
30. Spera PA, Ellison JA, Feuerstein GZ, et al. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett. 1998;251:189-192.
31. Yokoyma Y, Kitchens WC, Toth B, et al. Role of IL-10 in regulating proinflammatory cytokine release by Kupffer cells following trauma-hemorrhage. Am J Physiol Gastrointest Liver Physiol. 2004;286:G942-G946.
32. Bell MJ, Kochanek PM, Doughty LA, et al. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J Neurotrauma. 1997;14:451-456.
33. Fan L, Young PR, Barone FC, et al. Experimental brain injury induces expression of interleukin-1β mRNA in the rat brain. Brain Res Mol Brain Res. 1995;30:125-130.
34. Gourin CG, Shackford SR. Production of tumor necrosis factor-α and interleukin-1β by human cerebral microvascular endothelium after percussive trauma. J Trauma. 1997;42:1101-1107.
35. Holmin S, Schalling M, Hojeber B, et al. Delayed cytokine expression in rat brain following experimental contusion. J Neurosurg. 1997;86:493-504.
36. Hoch RC, Rodriguez R, Manning T, et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med. 1993;21:839-845.
37. Guilian D, Woodward J, Young DG, et al. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci. 1988;8:2485-2490.
38. Yong VW, Moumdjian R, Yong FP, et al. Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vitro. Proc Natl Acad Sci USA. 1991;88:7016-7020.
39. Barzo P, Marmarou A, Fatouros P, et al. Magnetic resonance imaging-monitored acute blood-brain barrier changes in experimental traumatic brain injury. J Neurosurg. 1996;85:1113-1121.
40. Osburg B, Peiser C, Domling D, et al. Effect of endotoxin on expression of TNF receptors and transport of TNF-alpha at the blood-brain barrier of the rat. Am J Physiol. 2002;283:E899-908.
41. Plotkin SR, Banks WA, Maness LM, et al. Differential transport of rat and human interleukin-1α across the blood-brain barrier and blood-testis barrier in rats. Brain Res. 2000;881:57-61.
42. Banks WA, Kastin AJ, Durham DA. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull. 1989;23:433-437.
43. Banks WA, Farr SA, La Scola ME, et al. Intravenous human interleukin-1α impairs memory processing in mice: Dependence on blood-brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther. 2001;299:536-541.
44. Kastin AJ, Akerstrom V, Pan W. Interleukin-10 as a CNS therapeutic: the obstacle of the blood-brain/blood-spinal cord barrier. Mol Brain Res. 2003;114:168-171.